1. Health of the population of the Republic of Kazakhstan and the activities of health organizations in 2017 . The statistical collection. Astana; 22 (Almaty), No. 3 (189), 2018 public health, pp. 35-39. http://www.mz.gov.kz/sites/default/files/pages/sbornik_2018.
Google Scholar2. Van Halm, VP, Peters, MJL, Voskuyl, AE, et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis. 2009;68:1395-1400.
Google Scholar | Crossref | Medline | ISI3. Martinez, E, Martorell, J, Riambau, V. Review of serum biomarkers in carotid atherosclerosis. J Vasc Surg. 2020;71:329-341.
Google Scholar | Crossref | Medline4. Södergren, A, Karp, K, Bengtsson, C, Möller, B, Rantapää-Dahlqvist, S, Wållberg-Jonsson, S. Biomarkers associated with cardiovascular disease in patients with early rheumatoid arthritis. PLoS One. 2019;14:e0220531.
Google Scholar | Crossref | Medline5. Gobbi, CA, Asbert, P, Alba, PB, et al. Marcadores subclínicos de aterosclerosis y factores de riesgo cardiovascular en artritis temprana. [Subclinical markers of atherosclerosis and cardiovascular risk factors in early arthritis]. Rev Fac Cien Med Univ Nac Cordoba. 2019;76:174-179 (Spanish).
Google Scholar | Crossref | Medline6. Gluvic, Z, Zaric, B, Resanovic, I, et al. Link between metabolic syndrome and insulin resistance. Curr Vasc Pharmacol. 2017;15:30-39.
Google Scholar | Crossref | Medline7. McCracken, E, Monaghan, M, Sreenivasan, S. Pathophysiology of the metabolic syndrome. Clin Dermatol. 2018;36:14-20.
Google Scholar | Crossref | Medline8. Sherling, DH, Perumareddi, P, Hennekens, CH. Metabolic syndrome. J Cardiovasc Pharmacol Ther. 2017;22:365-367.
Google Scholar | SAGE Journals | ISI9. Hallajzadeh, J, Safiri, S, Mansournia, M, et al. Metabolic syndrome and its components among rheumatoid arthritis patients: a comprehensive updated systematic review and meta-analysis. PLoS One. 2017;12:e0170361.
Google Scholar | Crossref | Medline10. Dessein, P, Tobias, M, Veller, M. Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol. 2006;33:2425-2432.
Google Scholar | Medline11. Karvounaris, SA, Sidiropoulos, PI, Papadakis, JA, et al. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis. 2007;66:28-33.
Google Scholar | Crossref | Medline | ISI12. Vergunst, CE, Van de Sande, MG, Lebre, MC, Tak, PP. The role of chemokines in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol. 2005;34:415-425.
Google Scholar | Crossref | Medline | ISI13. Zhang, Z, Wang, Q, Yao, J, et al. Chemokine receptor 5, a double-edged sword in metabolic syndrome and cardiovascular disease. Front Pharmacol. 2020;11:146.
Google Scholar | Crossref | Medline14. Francisco, V, Ruiz-Fernández, C, Pino, J, et al. Adipokines: linking metabolic syndrome, the immune system, and arthritic diseases. Biochem Pharmacol. 2019;165:196-206.
Google Scholar | Crossref | Medline15. Oner, SY, Volkan, O, Oner, C, Mengi, A, Direskeneli, H, Tasan, DA. Serum leptin levels do not correlate with disease activity in rheumatoid arthritis. Acta Reumatol Port. 2015;40:50-54.
Google Scholar | Medline16. Hammad, MH, Nasef, S, Musalam, D, Ahmed, MM, Osman, I, Hammad, MH. Resistin, an adipokine, its relation to inflammation in Systemic Lupus Erythematosus and Rheumatoid Arthritis. Middle East J Intern Med. 2014;7:3-9.
Google Scholar | Crossref17. Lee, YH, Bae, S-C. Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: a meta-analysis. Z Rheumatol. 2016;75:1021-1027.
Google Scholar | Crossref | Medline18. Migita, K. The serum levels of resistin in rheumatoid arthritis patients. Clin Exp Rheumatol. 2006;24:698-701.
Google Scholar | Medline19. Rivera-Bahena, CB, Xibillé-Friedmann, DX, González-Christen, J, Carrillo-Vázquez, SM, Montiel-Hernández, JL. Peripheral blood leptin and resistin levels as clinical activity biomarkers in Mexican Rheumatoid Arthritis patients. Reumatol Clin. 2016;12:323-326.
Google Scholar | Crossref | Medline20. Hulejová, H, Andrés Cerezo, L, Kuklová, M, et al. Novel adipokine fibroblast growth factor 21 is increased in rheumatoid arthritis. Physiol Res. 2012;61:489-494.
Google Scholar | Crossref | Medline21. Del Rincón, I, Polak, JF, O’Leary, DH, et al. Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis. Ann Rheum Dis. 2015;74:1118-1123.
Google Scholar | Crossref | Medline22. Kononoff, A, Vuolteenaho, K, Hämäläinen, M, et al. Metabolic syndrome, disease activity, and adipokines in patients with newly diagnosed inflammatory joint diseases. J Clin Rheumatol. Published online May 21, 2020. doi:10.1097/RHU.0000000000001412.
Google Scholar | Crossref | Medline23. Aletaha, D, Neogi, T, Silman, AJ, Funovits, J, Felson, DT, Bingham, CO, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569-2581.
Google Scholar | Crossref | Medline24. Arnett, FC, Edworthy, SM, Bloch, DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
Google Scholar | Crossref | Medline25. Alberti, KG, Zimmet, P, Shaw, J. Metabolic syndrome: a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469-480.
Google Scholar | Crossref | Medline | ISI26. Zhang, X, Zhao, JX, Sun, L, Liu, XY. Expression of CXCL16/CXCR6 in fibroblast-like synoviocytes in rheumatoid arthritis and its role in synoviocyte proliferation. Beijing Da Xue Xue Bao Yi Xue Ban. 2017;49:663-668 (Chinese).
Google Scholar | Medline27. Li, CH, Xu, LL, Zhao, JX, et al. CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2/STAT3 and p38/MAPK signaling pathway. Inflammation Res. 2016;65:193-202.
Google Scholar | Crossref | Medline28. Muhsin, HY, Kadri, ZHM, Ad’hiah, AH, Mayouf, KZ. Predictive significance of CXCL8, CXCL10 and CXCL16 in juvenile idiopathic and rheumatoid arthritis Iraqi patients. Egypt Rheumatol. Published online June 13, 2019. doi:10.1016/j.ejr.2019.06.002.
Google Scholar | Crossref29. Collado, A, Marques, P, Escudero, P, et al. Functional role of endothelial CXCL16/CXCR6-platelet-leucocyte axis in angiotensin II-associated metabolic disorders. Cardiovasc Res. 2018;114:1764-1775.
Google Scholar | Crossref | Medline30. Yoshino, T, Kusunoki, N, Tanaka, N, et al. Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern Med. 2011;50:269-275.
Google Scholar | Crossref | Medline31. Olama, SM, Senna, MK, Elarman, M. Synovial/serum leptin ratio in rheumatoid arthritis: the association with activity and erosion. Rheumatol Int. 2012;32:683-690.
Google Scholar | Crossref | Medline32. Rho, YH, Solus, J, Sokka, T, et al. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum. 2009;60:1906-1914.
Google Scholar | Crossref | Medline33. Fioravanti, A, Tenti, S, Bacarelli, MR, et al. Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition. Clin Exp Rheumatol. 2019;37:293-300.
Google Scholar | Medline34. Kontunen, P, Vuolteenaho, K, Nieminen, R, et al. Resistin is linked to inflammation, and leptin to metabolic syndrome, in women with inflammatory arthritis. Scand J Rheumatol. 2011;40:256-262.
Google Scholar | Crossref | Medline35. Abella, V, Scotece, M, Conde, J, et al. Adipokines, metabolic syndrome and rheumatic diseases. J Immunol Res. 2014;2014:343746.
Google Scholar | Crossref | Medline36. Šenolt, L, Housa, D, Vernerová, Z, et al. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis. 2007;66:458-463.
Google Scholar | Crossref | Medline | ISI37. Klein-Wieringa, IR, Van der Linden, MPM, Knevel, R, et al. Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis. Arthritis Rheum. 2011;63:2567-2574.
Google Scholar | Crossref | Medline38. Fadda, SM, Gamal, SM, Elsaid, NY, Mohy, AM. Resistin in inflammatory and degenerative rheumatologic diseases. Relationship between resistin and rheumatoid arthritis disease progression. Z Rheumatol. 2013;72:594-600.
Google Scholar | Crossref | Medline39. Montazerifar, F, Bolouri, A, Paghalea, RS, Mahani, MK, Karajibani, M. Obesity, serum resistin and leptin levels linked to coronary artery disease. Arq Bras Cardiol. 2016;107:348-353.
Google Scholar | Medline40. Mancuso, P, Bouchard, B. The impact of aging on adipose function and adipokine synthesis. Front Endocrinol (Lausanne). 2019;10:137.
Google Scholar | Crossref | Medline41. McCarey, D, Sturrock, RD. Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis. Clin Exp Rheumatol. 2009;27:S124-S126.
Google Scholar | Medline